Dextromethorphan Hydrobromide and Opioid Tolerance: A Compounding Opportunity for Pharmacists with Chronic Pain Patients

Author(s):  Kane Dana Lynn, Glasnapp Andrew

Issue:  Mar/Apr 1998 - Pain Management
View All Articles in Issue

Abstract:  The authors discuss opioid tolerance and the mechanisms of action responsible for it and show how dextromethorphan hydrobromide can be used to block this tolerance. The discussion includes its chemical characteristics, dosing/formulation considerations and storage/stability. A table provides information regarding Dextromethorphan Hydrobromide USP Capsules (Quantity: 100).

Related Categories: PAIN MANAGEMENT

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=624

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products